After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

Phase 3 trial of Biogen and UCB's dapirolizumab pegol shows significant improvement in lupus disease activity. Read more here ...

Fate Therapeutics, Inc. FATE presented encouraging initial clinical and translational data from the first patient treated in ...

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Lupus is a condition often shrouded in mystery. Presenting with a huge range of symptoms, it’s tricky to diagnose, tough to ...

"Lupus was the perfect disease for us!" showrunner David Shore says with a laugh ahead of the 20th anniversary.

Then there’s physical activity: Many of the symptoms of lupus, such as joint pain, fatigue, and depression, may make patients ...

For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's ...

The patient achieved clinical remission and low lupus disease activity state as of Month 6 follow-up. The patient continues on-study, in clinical remission, and free of all immunosuppressive therapies ...

There are multiple chapters near you. Select your preferred chapter.